|
|
 |
| |
|
Home > Drug Companies > Boehringer Ingelheim Pharma., Inc.
Boehringer Ingelheim Pharma., Inc.
Boehringer Ingelheim was founded in Ingelheim am Rein in 1885, where the corporate headquarters are still located today.
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. The route to success they have chosen is how they deliver Value through Innovation. Sharing their customer’s aspirations and needs and meeting them by finding new ways to achieve greater value in everything they do is one facet of it.
Boehringer Ingelheim group of companies is privately held and consistently dedicated to the long term interests of the corporation's stakeholders, including its customers, employees and the communities within which it operates.
In 1993 the Shareholders and the Board of Managing Directors of the Boehringer Ingelheim Corporation formulated a new Vision for Boehringer Ingelheim worldwide, built around the central concept of their corporate vision Value through Innovation.
The Vision was presented for the first time in February 1994 at an event held in conjunction with the International Management Conference of Boehringer Ingelheim.
Since then, their vision celebrated its 10th anniversary. In these 10 years their vision has helped them build on their strength and make the most of their distinctive character. Boehringer Ingelheim's corporate culture was guided by the concept of Vision and Leadership during these first 10 years.
Boehringer Ingelheim is a research driven group of companies dedicated to researching, developing, manufacturing and marketing pharmaceuticals that improve health and quality of life.
Their business consists of Prescription Medicines, Consumer Health Care and Animal Health. Activities grouped under Industrial Customer include Biopharmaceuticals and Chemicals. They focus on the production of innovative drugs and treatments that represent major therapeutic advances.
A drug manufacturer is a business entity engaged in making, assembling, processing or modifying devices, or mixing, producing or preparing drugs in dosage forms by encapsulating, entableting or other process, or packaging, repackaging or otherwise changing the container, wrapper or label of any package containing a drug or device in furtherance of the distribution of the drug or device from the original place of manufacture to the person who makes final delivery or sale to the ultimate consumer.
Back to Drug Companies
|
|
|
|
|
|
|
|